For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 33,379,321 | |||
| General and administrative | 6,787,987 | |||
| Total operating expenses | 40,167,308 | |||
| Loss from operations | -40,167,308 | |||
| Change in fair value of financial instruments | 5,592 | |||
| Other income | 442,569 | |||
| Total other income, net | 448,161 | |||
| Net (loss) income | -39,719,147 | |||
| Basic EPS | -22.61 | |||
| Diluted EPS | -22.61 | |||
| Basic Average Shares | 1,756,844 | |||
| Diluted Average Shares | 1,756,844 | |||
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN)